These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10777379)

  • 21. Effect of secretin on children with autism: a randomized controlled trial.
    Dunn-Geier J; Ho HH; Auersperg E; Doyle D; Eaves L; Matsuba C; Orrbine E; Pham B; Whiting S
    Dev Med Child Neurol; 2000 Dec; 42(12):796-802. PubMed ID: 11132252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretin for the treatment of autism.
    McQueen JM; Heck AM
    Ann Pharmacother; 2002 Feb; 36(2):305-11. PubMed ID: 11847953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What to measure in autism drug trials.
    Roseman B; Schneider E; Crimmins D; Bostwick H; Visintainer P; Jaskow PA; Accardo P
    J Autism Dev Disord; 2001 Jun; 31(3):361-2. PubMed ID: 11518490
    [No Abstract]   [Full Text] [Related]  

  • 25. Secretin in autism.
    Perry R; Bangaru BS
    J Child Adolesc Psychopharmacol; 1998; 8(4):247-8. PubMed ID: 10214929
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of secretin in the management of autism.
    Kern JK; Espinoza E; Trivedi MH
    Expert Opin Pharmacother; 2004 Feb; 5(2):379-87. PubMed ID: 14996634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment: secretin for autism: unproven treatment or ineffective treatment?
    Heisler MA; Guidry JR
    Ann Pharmacother; 2002; 36(7-8):1294-5; author reply 1295. PubMed ID: 12086571
    [No Abstract]   [Full Text] [Related]  

  • 28. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.
    Roberts W; Weaver L; Brian J; Bryson S; Emelianova S; Griffiths AM; MacKinnon B; Yim C; Wolpin J; Koren G
    Pediatrics; 2001 May; 107(5):E71. PubMed ID: 11331721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple doses of secretin in the treatment of autism: a controlled study.
    Sponheim E; Oftedal G; Helverschou SB
    Acta Paediatr; 2002; 91(5):540-5. PubMed ID: 12113323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretin as a treatment for autism: a review of the evidence.
    Esch BE; Carr JE
    J Autism Dev Disord; 2004 Oct; 34(5):543-56. PubMed ID: 15628608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel treatments for autistic spectrum disorders.
    Levy SE; Hyman SL
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretin: cure or snake oil for autism in the new millennium? (response).
    Herlihy WC
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):112-3; author reply 113-4. PubMed ID: 10697126
    [No Abstract]   [Full Text] [Related]  

  • 33. Secretin: cure or snake oil for autism in the new millennium?
    Lightdale JR; Heyman MB
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):114-5. PubMed ID: 10435643
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood autism: a circuit syndrome?
    Lee DA; Lopez-Alberola R; Bhattacharjee M
    Neurologist; 2003 Mar; 9(2):99-109. PubMed ID: 12808372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary: the primacy of the scientific method.
    Tanguay PE
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1322-3. PubMed ID: 12410074
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on secretin. III. Purification of porcine secretin by high performance liquid chromatography and comparison of the product with synthetic secretin.
    Uchiyama M; Sato T; Yoshino H; Tsuchiya Y; Tsuda T; Kawashima H; Nakatani T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2006-10. PubMed ID: 4053224
    [No Abstract]   [Full Text] [Related]  

  • 38. Early negative results not the last word on secretin/autism story.
    Gordon D
    Gastroenterology; 2000 Feb; 118(2):250. PubMed ID: 10691370
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical and biological properties of porcine secretin and secretin analogues modified in positions 3 and 4.
    König W; Geiger R; Wissmann H; Bickel M; Obermeier R; Teetz W; Uhmann R
    Gastroenterology; 1977 Apr; 72(4 Pt.2):797-800. PubMed ID: 838238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretin treatment for autistic disorder: a critical analysis.
    Patel NC; Yeh JY; Shepherd MD; Crismon ML
    Pharmacotherapy; 2002 Jul; 22(7):905-14. PubMed ID: 12126223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.